추가 설명:
Arotinolol Hydrochloride (CAS 68377-92-4) is the mixed alpha/beta-adrenergic blocker marketed under the tradename Almarl, first described in the scientific literature in 1979 by Sumitomo Chemical as an antiarrhythmic compound, and which also acts as a β3 receptor agonist. Manufactured directly by Hebei Shengmei Medical Technology Co., Ltd. to pharmaceutical grade in compliance with USP and EP standards, paid samples are available, and the product is sold across Central/South America, Asia, and the Middle East.
평가 & 댓글 남기기